Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Targeted Oncology|December 22, 2015
A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal CancerFotios Loupakis, Alexander Stein, Marc Ychou, et al.Oncology|May 25, 2011
Self-reported compliance with capecitabine: findings from a prospective cohort analysisRalph Winterhalder, Pierre Hoesli, Geoffrey Delmore, et al.Scientific Reports|May 6, 2021
Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinomaGundula Streubel, Sabine Schrepfer, Hannah Kallus, et al.Immunology Letters|May 26, 2004
HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cellsMarcus Schuchmann, Frank Hermann, Johannes Herkel, et al.Journal of Cardiovascular Pharmacology|June 24, 2006
Protection of endothelial function: targets for nutritional and pharmacological interventionsIsabella Sudano, Lukas E Spieker, Frank Hermann, et al.Oncology Research and Treatment|May 24, 2014
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort studyAndreas Wicki, Frank Hermann, Vincent Prêtre, et al.Journal for Immunotherapy of Cancer|November 10, 2019
Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)Anne Catherine Bretz, Ulrike Parnitzke, Kerstin Kronthaler, et al.Thrombosis Research|September 16, 2008
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemiaFrank Hermann, Frank Enseleit, Lukas E Spieker, et al.International Journal of Cardiology|August 28, 2007
Auricall. A new device for a non-invasive, wireless, continuous monitoring of oxygen saturation and heart rate in patients with heart failureIsabella Sudano, Andreas J Flammer, Frank Hermann, et al.Hepatology (Baltimore, Md.)|December 25, 2002
Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failureMarcus Schuchmann, Eugene E Varfolomeev, Frank Hermann, et al.Pageof 2